Newsroom » Experts
Doris Rouse
rouse rti.org
919-541-6980

Doris J. Rouse

Vice President, Global Health Technologies

Doris Rouse, PhD, manages the coordination of diverse disciplines to address major global health needs. Currently, she is the project director for two Gates Foundation grants: Venture Investment Technical Assistance to develop new products for global health, and Maternal and Neonatal Directed Assessment of Technology (MANDATE) to identify and advance opportunities for improving maternal and neonatal health in low resource settings. Dr. Rouse is the principal investigator for a program funded by the National Institutes of Health to commercialize new treatments for tuberculosis. She has extensive experience in forming public and private consortia, such as the Global Alliance for TB Drug Development. Dr. Rouse serves on the Global Health Advisory Committee for the University of North Carolina School of Public Health. In her tenure as director of the Center for Technology Applications at RTI, she managed technology assessment, outlicensing, and technology sourcing projects for numerous government and corporate clients.

Education

PhD, Physiology and Pharmacology, Duke University; BA, Chemistry, Duke University.

Publications

The MANDATE model for evaluating interventions to reduce postpartum hemorrhage — International Journal of Gynecology & Obstetrics
McClure, E.M., Rouse, D.J., MacGuire, E.R., Jones, B., Griffin, J.B., Jobe, A.H., et al. (Apr 2013)
Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients — Antimicrobial Agents and Chemotherapy
Diacon, A.H., Dawson, R., Hanekom, M., Narunsky, K., Maritz, S.J., Venter, A., Donald, P.R., van Niekerk, C., Whitney, K., Rouse, D.J., et al. (Aug 2010)
Chlorhexidine Vaginal and Infant Wipes to Reduce Perinatal Mortality and Morbidity A Randomized Controlled Trial — Obstetrics and Gynecology
Saleem, S., Rouse, D.J., McClure, E.M., Zaidi, A., Reza, T., Yahya, Y., Memon, I.A., Khan, N.H., Memon, G., Soomro, N., Pasha, O., Wright, L.L., Moore, J., et al. (Jun 2010)
Assessment of the effects of the nitroimidazo-oxazine PA-824 on renal function in healthy subjects — Antimicrobial Agents and Chemotherapy
Ginsberg, A.M., Laurenzi, M.W., Rouse, D.J., Whitney, K.D., & Spigelman, M.K. (Sep 2009)
Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects — Antimicrobial Agents and Chemotherapy
Ginsberg, A.M., Laurenzi, M.W., Rouse, D.J., Whitney, K.D., & Spigelman, M.K. (Jun 2009)
View all publications by Doris J. Rouse

Expertise